I’ve just read an enjoyable commentary in Antimicrobial Agents and Chemotherapy exploring barriers and solutions to implementing proactive WGS in IPC. It links in nicely with a post I wrote towards the end of last year along similar lines. So what are the key barriers and how do we overcome them?